• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.病毒状态对乙型肝炎相关肝细胞癌发生的意义。
World J Gastroenterol. 2014 May 28;20(20):5999-6005. doi: 10.3748/wjg.v20.i20.5999.
2
Risk stratification for hepatitis B virus related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌的风险分层。
J Gastroenterol Hepatol. 2013 Jan;28(1):10-7. doi: 10.1111/jgh.12010.
3
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.高乙肝核心相关抗原水平与中等病毒载量慢性乙型肝炎病毒感染者肝细胞癌风险增加相关。
Gastroenterology. 2019 Dec;157(6):1518-1529.e3. doi: 10.1053/j.gastro.2019.08.028. Epub 2019 Aug 27.
4
Perspectives and control of hepatitis B virus infection in Taiwan.台湾地区乙肝病毒感染的现状与防控
J Formos Med Assoc. 2015 Oct;114(10):901-9. doi: 10.1016/j.jfma.2015.06.003. Epub 2015 Jul 13.
5
Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.与肝细胞癌发生相关的乙型肝炎病毒基因组变化。
World J Gastroenterol. 2016 Jun 21;22(23):5393-9. doi: 10.3748/wjg.v22.i23.5393.
6
Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.乙肝表面抗原阳性肝细胞癌中核心启动子T1762/A1764和前核心A1896基因突变:与慢性携带者的比较
Liver Int. 2007 Dec;27(10):1356-63. doi: 10.1111/j.1478-3231.2007.01585.x. Epub 2007 Sep 26.
7
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.乙肝 e 抗原血清学转换后乙型肝炎表面抗原血清学清除患者的肝细胞癌和长期结局及预测评分。
Hepatology. 2018 Aug;68(2):462-472. doi: 10.1002/hep.29874. Epub 2018 Jun 6.
8
Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.乙型肝炎病毒基因混合体、C2和B2亚基因型在肝细胞癌中的作用:与同一地区慢性乙型肝炎和无症状携带者状态的比较。
Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12.
9
Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.乙肝病毒载量及基础核心启动子突变在乙肝携带者肝细胞癌中的作用
J Infect Dis. 2006 May 1;193(9):1258-65. doi: 10.1086/502978. Epub 2006 Apr 4.
10
Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.印度喀拉拉邦肝病患者中乙型肝炎病毒 A1 亚型占优势。
World J Gastroenterol. 2013 Dec 28;19(48):9294-306. doi: 10.3748/wjg.v19.i48.9294.

引用本文的文献

1
The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.乙型肝炎表面蛋白的 N -linked 糖基化修饰影响细胞自噬、HBV 复制和 HBV 分泌。
PLoS One. 2024 Mar 15;19(3):e0299403. doi: 10.1371/journal.pone.0299403. eCollection 2024.
2
Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis.评估中医作为新辅助治疗在降低乙型肝炎相关性肝硬化患者肝细胞癌发病率方面的临床疗效:一项系统评价和荟萃分析。
Heliyon. 2024 Jan 11;10(3):e24437. doi: 10.1016/j.heliyon.2024.e24437. eCollection 2024 Feb 15.
3
Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.术前炎症指标对乙型肝炎相关肝细胞癌术后早期复发的预测价值
Front Oncol. 2023 Jul 13;13:1142168. doi: 10.3389/fonc.2023.1142168. eCollection 2023.
4
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy.预测接受有限疗程抗病毒治疗的慢性乙型肝炎患者的肝细胞癌风险
Cancers (Basel). 2023 Jun 25;15(13):3343. doi: 10.3390/cancers15133343.
5
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.北美 HIV/HBV 共感染人群中乙型肝炎病毒血症与 HCC 风险。
Hepatology. 2021 Sep;74(3):1190-1202. doi: 10.1002/hep.31839. Epub 2021 Jun 22.
6
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy.接受抗病毒治疗的慢性乙型肝炎患者肝细胞癌风险评估
Clin Mol Hepatol. 2016 Sep;22(3):319-326. doi: 10.3350/cmh.2016.0045. Epub 2016 Sep 25.

本文引用的文献

1
Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.乙型肝炎病毒前 S 区缺失和复杂突变与中国启东青年肝细胞癌的关系。
PLoS One. 2013;8(3):e59583. doi: 10.1371/journal.pone.0059583. Epub 2013 Mar 28.
2
Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.A1896、T1653 和 T1762/A1764 突变在基因型 c2 乙型肝炎病毒中对肝细胞癌发展的协同作用。
J Viral Hepat. 2013 Mar;20(3):219-24. doi: 10.1111/j.1365-2893.2012.01654.x. Epub 2012 Aug 16.
3
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.HBV 和 HCV 相关肝细胞癌的发病机制。
Nat Rev Cancer. 2013 Feb;13(2):123-35. doi: 10.1038/nrc3449.
4
The role of HBsAg quantification for monitoring natural history and treatment outcome.HBsAg 定量检测在监测自然史和治疗结局中的作用。
Liver Int. 2013 Feb;33 Suppl 1:125-32. doi: 10.1111/liv.12075.
5
Epidemiology of viral hepatitis and hepatocellular carcinoma.病毒性肝炎与肝细胞癌的流行病学。
Gastroenterology. 2012 May;142(6):1264-1273.e1. doi: 10.1053/j.gastro.2011.12.061.
6
Hepatitis B surface antigen quantification: not what it seems on the surface.乙肝表面抗原定量:并非表面看上去那么简单。
Hepatology. 2012 Aug;56(2):411-4. doi: 10.1002/hep.25732. Epub 2012 Jul 6.
7
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.高水平的乙肝表面抗原会增加低 HBV 载量患者发生肝细胞癌的风险。
Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. Epub 2012 Feb 11.
8
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.乙肝表面抗原阴性低病毒载量患者自发表面抗原消失的决定因素。
Hepatology. 2012 Jan;55(1):68-76. doi: 10.1002/hep.24615.
9
Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.乙型肝炎病毒核心启动子突变通过下调 SKP2 及其靶标 p21 促进肝癌发生。
Gastroenterology. 2011 Oct;141(4):1412-21, 1421.e1-5. doi: 10.1053/j.gastro.2011.06.048. Epub 2011 Jun 24.
10
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.血清乙型肝炎表面抗原水平可预测乙型肝炎 e 抗原血清学转换者的表面抗原丢失。
Gastroenterology. 2011 Aug;141(2):517-25, 525.e1-2. doi: 10.1053/j.gastro.2011.04.046. Epub 2011 Apr 28.

病毒状态对乙型肝炎相关肝细胞癌发生的意义。

Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.

作者信息

Qu Li-Shuai, Zhou Guo-Xiong

机构信息

Li-Shuai Qu, Guo-Xiong Zhou, Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2014 May 28;20(20):5999-6005. doi: 10.3748/wjg.v20.i20.5999.

DOI:10.3748/wjg.v20.i20.5999
PMID:24876722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4033439/
Abstract

Hepatitis B virus (HBV) infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of developing hepatocellular carcinoma (HCC). Interactions that occur among host, environmental, and viral factors determine the natural course and predict the prognosis of patients with chronic HBV infection. In the past decades, several important viral factors of predictive of HCC have been identified, such as high hepatitis B surface antigen level, seropositivity of hepatitis B e antigen, high viral load, viral genotype, and specific viral sequence mutations. Identification of certain viral risk factors for HCC development and stratification of patient risk are very important to perform future surveillance programs. In this article, we thus reviewed the risk of viral factors involved in hepatocarcinogenesis.

摘要

乙型肝炎病毒(HBV)感染仍然是一个具有挑战性的全球健康问题,超过3.5亿人被慢性感染并有发展为肝细胞癌(HCC)的风险。宿主、环境和病毒因素之间的相互作用决定了慢性HBV感染患者的自然病程并预测其预后。在过去几十年中,已经确定了几种预测HCC的重要病毒因素,如高乙肝表面抗原水平、乙肝e抗原血清阳性、高病毒载量、病毒基因型和特定病毒序列突变。识别HCC发生的某些病毒风险因素以及对患者风险进行分层对于开展未来的监测计划非常重要。因此,在本文中,我们综述了参与肝癌发生的病毒因素的风险。